Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
09/2010
09/23/2010US20100240739 Widespread gene delivery to motor neurons using peripheral injection of aav vectors
09/23/2010US20100240728 Co-Crystals of Pyrrolidinones
09/23/2010US20100240726 Compositions for treating amyloid associated diseases
09/23/2010US20100240724 Edible Film
09/23/2010US20100240720 Allosteric jnk inhibitors
09/23/2010US20100240719 Novel alpha-(n-sulfonamido)acetamide compounds incorporating deuterium as inhibitors of beta amyloid peptide production
09/23/2010US20100240718 Novel heteroaryl-substituted acetone derivative, suitable for inhibiting phospholipase a2
09/23/2010US20100240708 Alpha-(N-Benzenesulfonamido)Cycloalkyl Derivatives
09/23/2010US20100240707 1,3,5-trisubstituted triazole derivative
09/23/2010US20100240706 1,3-disubstituted-4-phenyl-1h-pyridin-2-ones
09/23/2010US20100240704 Method of modulating stress-activated protein kinase system
09/23/2010US20100240703 Oxyimino compounds and the use thereof
09/23/2010US20100240699 Method of treating sensorimotor disorders with alpha-2 adrenergic receptor agonists
09/23/2010US20100240696 3-substituted-2(arylalkyl)-1-azabicycloalkanes and methods of use thereof
09/23/2010US20100240695 Stabilized zolpidem pharmaceutical compositions
09/23/2010US20100240692 [1,10]-phenanthroline derivatives for the treatment of neurodegenerative or haematological diseases
09/23/2010US20100240691 Morphinan derivatives with high oral bioavailability
09/23/2010US20100240690 Compositions containing opioid antagonists
09/23/2010US20100240689 N-aryl azaspiroalkene and azaspiroalkane compounds and methods of preparation and use thereof
09/23/2010US20100240688 1,3-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2h,1 h-1,4 bipyridinyl-2-ones
09/23/2010US20100240686 Chemical compounds
09/23/2010US20100240679 4-Phenylpiperidine Derivatives as Renin Inhibitors
09/23/2010US20100240677 Compounds as PDE IV and TNF Inhibitors
09/23/2010US20100240675 Therapeutic agents useful for treating pain
09/23/2010US20100240674 Use of compounds derived from benzamidine methanesulphonate or a pharmaceutically acceptable salt thereof, for example imatinib mesylate, for the preparation o f a drug for the treatment of neurodegenerative niemann-pick c disease (npc)
09/23/2010US20100240670 4-[(arylmethyl)aminomethyl]piperidine derivatives, their preparation and their therapeutic application
09/23/2010US20100240663 Heterocycles as potassium channel modulators
09/23/2010US20100240661 Azabicyclo [3. 1. 0] hexyl derivatives as modulators of dopamine d3 receptors
09/23/2010US20100240653 Biphenyl sulfonyl and phenyl-heteroaryl sulfonyl modulators of the histamine h3-receptor useful for the treatment of disorders related thereto
09/23/2010US20100240650 Substituted pyrrolines as kinase inhibitors
09/23/2010US20100240648 Hexahydro-pyrrolo-isoquinoline compounds
09/23/2010US20100240647 Treatment of Alzheimer's Disease and Related Conditions
09/23/2010US20100240641 Aldosterone Synthase and/or 11B-hydroxylase Inhibitors
09/23/2010US20100240640 (THIO) Carbamoyl-Cyclohexane Derivatives as D3/D2 Receptor Antagonists
09/23/2010US20100240635 Benzothiadiazepine compounds, a process for their preparation and pharmaceutical compositions containing them
09/23/2010US20100240606 Associations of xanthogenates and cyclodextrins, and their use
09/23/2010US20100240603 Expression inhibitor of nuclear transcription factor ap-1 and pharmaceuticals and products using the same
09/23/2010US20100240601 Coordination Complexes, Pharmaceutical Solutions Comprising Coordination Complexes, and Methods of Treating Patients
09/23/2010US20100240588 Compound for use in the treatment of peripheral neuropathies
09/23/2010US20100240583 Soluble protein and utilization of the same
09/23/2010US20100240582 Peptides and related molecules that modulate nerve growth factor activity
09/23/2010US20100240580 Azoloarine derivatives, method for the production thereof, pharmaceuticals containing these compounds and the use thereof
09/23/2010US20100240576 Anticonvulsant combination therapy
09/23/2010US20100239694 compositions of Acai fruit and Jucara fruit with high antioxidant capability and cyclooxygenase-inhibitory activity, and their uses
09/23/2010US20100239693 Cannabinoid-containing plant extracts as neuroprotective agents
09/23/2010US20100239646 Sublingual methotrexate and methotrexate patches
09/23/2010US20100239633 Immunoglobulin constant region fc receptor binding agents
09/23/2010US20100239631 Thiopyrimidine-based compounds and uses thereof
09/23/2010US20100239603 Combinations of Botanical Extracts for Promoting Cardiovascular Health
09/23/2010US20100239597 Anti-ADDL monoclonal antibody and use thereof
09/23/2010US20100239591 Monoclonal antibody for app
09/23/2010US20100239580 Taci-immunoglobulin fusion proteins for treatment of optic neuritis
09/23/2010US20100239573 METHOD OF INHIBITING COMPLEMENT ACTIVATION WITH FACTOR Bb SPECIFIC ANTIBODIES
09/23/2010US20100239570 Moncolonal amyloid beta (abeta) - specific antibody and uses thereof
09/23/2010US20100239562 Kv CHANNELS IN NEURODEGENERATION AND NEUROPROTECTION
09/23/2010US20100239557 Compositions and methods of using chondroitinase abci mutants
09/23/2010US20100239541 Transplantation of human neural cells for treatment of neurodegenerative conditions
09/23/2010US20100239540 Peptide Linked Cell Matrix Materials for Stem Cells and Methods of Using the Same
09/23/2010US20100239530 Ifnar2 mutants, their production and use
09/23/2010US20100239528 Treating or Ameliorating a Neuroinflammatory or Demyelinating Disorder with Prolactin and Interferon-Beta
09/23/2010US20100239523 Tlr modulators and methods for using the same
09/23/2010US20100239500 Substituted triazine compounds for nerve regeneration
09/23/2010US20100236562 Inhalable composition
09/23/2010DE102009014165A1 Product, useful e.g. to treat and prevent disorders or diseases of lungs, cardiovascular and neuronal system caused by inhalation of tobacco smoke and respiratory diseases e.g. asthma, bronchitis and chronic cough, comprises cobalamin
09/23/2010DE102009013613A1 Trockenverarbeitung von Retigabin Dry processing of retigabine
09/23/2010DE102009013225A1 Verwendung von Pflanzen der Gattung Sideritis und Extrakten daraus zur Behandlung des Aufmerksamkeitsdefizit-Hyperaktivitätssyndroms Use of plants of the genus Sideritis and extracts thereof for the treatment of attention deficit hyperactivity syndrome
09/23/2010CA2756003A1 Amide derivatives as neuropeptide y5 receptor ligands
09/23/2010CA2755738A1 A novel alpha-(n-sulfonamido)acetamide compound as an inhibitor of beta amyloid peptide production
09/23/2010CA2755697A1 Amide derivative
09/23/2010CA2755683A1 Method for therapeutic use
09/23/2010CA2755528A1 N-[(6-aza-bicyclo[3.2.1]oct-5-yl)-aryl-methyl]-heterobenzamide derivatives, preparation thereof, and therapeutic use of same
09/23/2010CA2755526A1 Derivatives of n-[(2-aza-bicyclo[2.1.1]hex-1-yl)-aryl-methyl]-heterobenzamide, preparation thereof and application of same in therapeutics
09/23/2010CA2755436A1 Peptides for inhibiting igf-1
09/23/2010CA2754605A1 Compounds
09/23/2010CA2748889A1 Compositions and methods for blood-brain barrier delivery of igg-decoy receptor fusion proteins
09/22/2010EP2230305A1 Rnai modulation of the rho-a gene and uses thereof
09/22/2010EP2230243A1 Pharmaceutical compounds
09/22/2010EP2230234A1 Process for the preparation of rufinamide
09/22/2010EP2229950A1 Use of plants of the sideritis genus and extracts from same for treating attention deficit/hyperactivity disorder
09/22/2010EP2229943A1 Compounds for use in the treatment of peripheral neuropathy
09/22/2010EP2229451A1 Materials and methods for inhibiting mammalian s-nitrosoglutathione reductase
09/22/2010EP2229408A1 Peptide derived from neurotensin receptor 3 and use thereof in the treatment of psychiatric diseases
09/22/2010EP2229383A1 Isoxazolo-pyrazine derivatives
09/22/2010EP2229381A1 Gamma secretase modulators
09/22/2010EP2229375A1 Gamma secretase modulators
09/22/2010EP2229371A1 Cyclic triazo and diazo sodium channel blockers
09/22/2010EP2229351A1 Process for the production of 2-ý4-(3- or 2-fluorobenzyloxy)benzylamino¨propanamides with high purity degree
09/22/2010EP2229185A2 Co-administration of an agent linked to an internalization peptide with an anti-inflammatory
09/22/2010EP2229150A2 Systems and methods for delivery of materials
09/22/2010EP2076506B1 Heterocyclic-substituted piperidines as orl-1 ligands
09/22/2010EP1978967B1 Quinazolinone derivatives as vanilloid antagonists
09/22/2010EP1896477B1 Aspartyl protease inhibitors
09/22/2010EP1809271B9 Use of (r)-(halobenzyloxy) benzylamino-propanamides as sodium and/or calcium channel selective modulators
09/22/2010EP1799643B1 Indolone derivatives, processes for preparing them and their uses
09/22/2010EP1786766B1 Compounds which potentiate glutamate receptor and uses thereof in medicine
09/22/2010EP1692114B1 Novel benzimidazole and imidazopyridine derivatives and use thereof as a medicament
09/22/2010EP1682549B1 Imidazo[1,2-a]pyridine anxiolytics
09/22/2010EP1620399B1 Indolone-acetamide derivatives, processes for preparing them and their uses
09/22/2010EP1599464B1 Novel cyclic urea derivatives, preparation method thereof and pharmaceutical use of same as kinase inhibitors
09/22/2010EP1401853B1 Modulators of pharmacological agents
1 ... 433 434 435 436 437 438 439 440 441 442 443 444 445 446 447 448 449 450 451 452 453 ... 1833